With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies||Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD||Young Investigator Grants||2021||Ohio|
|Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia||Children's Hospital of Philadelphia / Jenny Ruiz, MD||Young Investigator Grants||2021||Pennsylvania|
|Dissecting Functional uORFs as a Source of Cancer Genes in High-Risk Medulloblastoma||Dana-Farber Cancer Institute / John Prensner, MD/PhD||Young Investigator Grants||2021||Massachusetts|
|Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma||Dana-Farber Cancer Institute / Riaz Gillani, MD||Young Investigator Grants||2021||Massachusetts|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma||Emory University / Shubin Shahab, MD/PhD||Young Investigator Grants||2021||Georgia|
|Targeting CCAAT/enhancer binding proteins CEBPB and CEBPD in neuroblastoma||Columbia University / Darrell Yamashiro, MD/PhD||Innovation Grants||2021||New York|
|In-vivo characterization of MYCN-driven immunosuppression||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2021||California|
|GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma||Board of Trustees of the Leland Stanford Junior University / Michelle Monje||Catalyst Grants||2021||California|
|Choline Kinase and Alkylating Agent Resistance in Refractory Childhood Leukemias||Boston Children's Hospital / Alejandro Gutierrez, MD||Innovation Grants||2021||Massachusetts|